Developing new oral targeted therapies for RA can be challenging
Crossref DOI link: https://doi.org/10.1038/nrrheum.2014.187
Published Online: 2014-11-11
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fleischmann, Roy M.
Text and Data Mining valid from 2014-11-11
Article History
First Online: 11 November 2014
Competing interests
: The author declares no competing financial interests.